Award recordCONTRACT

LUMINEX CORP

PIID 36C25022N0060· VHA· 250-NETWORK CONTRACT OFFICE 10 (36C250)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2022· $240,000 net obligations· UEI VLLHHV5E3AL1· TX

Description

COVID-19 NXTAG EXTENDED PANELS

First action · last action
2021-10-13 · 2021-12-01
Transactions
2
First transaction's obligation
$480,000
Base + all options value (sum of deltas)
$240,000
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C25021A0007
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$480,000$0Base award · 2021-10-13 · this action $480,000 · running total $480,000Modification P00001 · 2021-12-01 · this action -$240,000 · running total $240,000
  • Base2021-10-13+$480,000= $480,000
  • Mod P000012021-12-01-$240,000= $240,000
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-10-13+$480,000$480,000COVID-19 NXTAG EXTENDED PANELS
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2021-12-01−$240,000$240,000COVID-19 NXTAG EXTENDED PANELS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI VLLHHV5E3AL1)

AwardOffice · PSC / listingNet obligationsFY
36C25726P0700257-NETWORK CONTRACT OFFICE 17 (36C257) · J066 · MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT$7,790FY2026
36C24126N0575241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$93,749FY2026
36C24426N0663244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$121,316FY2026
36C24526F0002245-NETWORK CONTRACT OFFICE 5 (36C245) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$41,461FY2026
36C24425N0821244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$121,316FY2025
36C24125N0845241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$95,000FY2025

Other recipients under 6550 from 250-NETWORK CONTRACT OFFICE 10 (36C250) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25026N0794ROCHE DIAGNOSTICS CORPORATION250-NETWORK CONTRACT OFFICE 10 (36C250)$200,000FY2026
36C25026N0788ROCHE DIAGNOSTICS CORPORATION250-NETWORK CONTRACT OFFICE 10 (36C250)$135,282FY2026
36C25026N0718ABBOTT LABORATORIES INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$212,150FY2026
36C25026N0778LEICA MICROSYSTEMS INC.250-NETWORK CONTRACT OFFICE 10 (36C250)$120,282FY2026
36C25026F0645GOVERNMENT SCIENTIFIC SOURCE INC250-NETWORK CONTRACT OFFICE 10 (36C250)$53,963FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25022N0060_3600_36C25021A0007_3600 · retrieved 2026-09-26.